P/E ratio for Cel-Sci (CVM)
P/E ratio as of May 2024 (TTM): -1.84
According to Cel-Sci 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.84416. At the end of 2022 the company had a P/E ratio of -2.76.
P/E ratio history for Cel-Sci from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -2.76 | -65.34% |
| 2021 | -7.98 | -41.16% |
| 2020 | -13.6 | 30.4% |
| 2019 | -10.4 | 381.85% |
| 2018 | -2.16 | 213.98% |
| 2017 | -0.6873 | -12.81% |
| 2016 | -0.7883 | -36.26% |
| 2015 | -1.24 | 5.33% |
| 2014 | -1.17 | -34.33% |
| 2013 | -1.79 | -59.45% |
| 2012 | -4.41 | 64.21% |
| 2011 | -2.69 | -73.8% |
| 2010 | -10.3 | 116.39% |
| 2009 | -4.74 | 30.67% |
| 2008 | -3.63 | -28.92% |
| 2007 | -5.10 | -8.93% |
| 2006 | -5.60 | -54.29% |
| 2005 | -12.3 | -18.33% |
| 2004 | -15.0 | 83.96% |
| 2003 | -8.15 | 870.7% |
| 2002 | -0.8400 | -52.25% |
| 2001 | -1.76 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.7 | -682.01% | 🇺🇸 USA |
 Amgen AMGN | 19.6 | -1,162.93% | 🇺🇸 USA |
 Xencor XNCR | -11.2 | 506.36% | 🇺🇸 USA |
 Curis CRIS | -1.60 | -13.29% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -6.99 | 279.03% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -3.66 | 98.25% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -0.1598 | -91.34% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -0.3156 | -82.89% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.